Clinical Trial Update: ACT-GLOBAL Adaptive Platform Trial for Stroke [Phase 3]

View source ↗

Summary

The ACT-GLOBAL adaptive platform trial for stroke is in Phase 3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: The George Institute | Conditions: Stroke | Phase 3 | Status: RECRUITING